Junya Hata

Dr. Junya Hata

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
MMMakoto Matsushita
Makoto Matsushita
KFKazutoshi Fujita
Kazutoshi Fujita
DMDaisuke Motooka
Daisuke Motooka
KHKoji Hatano
Koji Hatano
JHJunya Hata
Junya Hata
NNNorio Nonomura
Norio Nonomura
Matsushita M, et al. World J Mens Health. 2022 Jul;40(3):517-525. https://doi.org/10.5534/wjmh.210190

Verified
Journal Article
Open access
PDF file
JHJunya Hata
Junya Hata
YHYuki Harigane
Yuki Harigane
KMKanako Matsuoka
Kanako Matsuoka
HAHidenori Akaihata
Hidenori Akaihata
KYKei Yaginuma
Kei Yaginuma
YKYoshiyuki Kojima
Yoshiyuki Kojima
Benign prostatic hyperplasia (BPH) is a chronic proliferative disease showing stromal-dominant proliferation. However, the detailed proliferation mechanism has remained unclear. Although aging and androgen have been reported as definitive risk factors for BPH, recent studies have focused on the involvement of androgen-independent factors. Androgen-independent factors include ischemia, oxidative stress, metabolic syndrome, infection, autoimmune reactions, and inflammation, with inflammation in BPH tissues playing a central role in the BPH proliferative process. Inflammation in BPH tissues by various factors finally leads to tissue remodeling and stromal proliferation through the wound healing process of the prostate. To elucidate the proliferative mechanism of BPH, a study using whole-genome gene expression analysis in a stromal-dominant BPH rat model was performed and showed that immune response-related pathways and complement classical pathways are activated. Furthermore, expression analysis using this BPH rat model showed that the autoimmune reaction triggered complement pathway activation in the proliferative process of BPH. BPH is a multifactorial disease, and understanding the role of androgen-independent factors including immune responses contributes to elucidating the pathogenesis of BPH. Androgen-independent factors may lead to new therapeutic targets for BPH, and further development of this research is expected.

1 August 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
SHseiji hoshi
seiji hoshi
KYKei Yaginuma
Kei Yaginuma
SMSatoru Meguro
Satoru Meguro
AOAkifumi Onagi
Akifumi Onagi
KMKanako Matsuoka
Kanako Matsuoka
YKYoshiyuki Kojima
Yoshiyuki Kojima
Theranostics (therapy + diagnosis) targeting prostate-specific membrane antigen (PSMA) is an emerging therapeutic modality that could alter treatment strategies for prostate cancer. Although PSMA-targeted radioligand therapy (PSMA-RLT) has a highly therapeutic effect on PSMA-positive tumor tissue, the efficacy of PSMA-RLT depends on PSMA expression. Moreover, predictors of treatment response other than PSMA expression are under investigation. Therefore, the optimal patient population for PSMA-RLT remains unclear. This review provides an overview of the current status of theranostics for prostate cancer, focusing on PSMA ligands. In addition, we summarize various findings regarding the efficacy and problems of PSMA-RLT and discuss the optimal patient for PSMA-RLT.

30 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JHJunya Hata
Junya Hata
TMTakeshi Machida
Takeshi Machida
KMKanako Matsuoka
Kanako Matsuoka
SHSeiji Hoshi
Seiji Hoshi
HAHidenori Akaihata
Hidenori Akaihata
YKYoshiyuki Kojima
Yoshiyuki Kojima
The pathophysiology of benign prostatic hyperplasia (BPH) remained unclear. Here, we concentrated on the complement activation in the growth of BPH using a rat model. BPH tissues were harvested from rats after rat urogenital sinus implantation. The local expression and deposition levels of C1q, C3, mannose-binding lectin (MBL), factor B (FB), and C5b-9 in the rat and human BPH tissues were analyzed by real-time RT-PCR, western blotting and immunohistochemistry (IHC). Serum IgG levels in the rat BPH model were analyzed by ELISA, and IHC was used to assess tissue localization. Proteins binding serum IgG autoantibody in the BPH rats were isolated by immunoprecipitation. C1q, C3, MBL, FB and C5b-9 were highly localized in rat BPH tissues compared to normal tissues. In contrast, C3, FB and C5b-9, but not C1q and MBL, were abundantly detected in human BPH tissues compared to normal tissues. Diffuse localization of IgG in rat BPH tissues was found. Heat shock protein 90, annexin, α-smooth muscle actin, and β-actin were identified as targets for IgG autoantibodies in the BPH model. Our results strongly suggested the role for complement activation in the growth process of BPH, likely triggered by classical pathway activation with autoantibodies.

14 November 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
KMKanako Matsuoka
Kanako Matsuoka
HAHidenori Akaihata
Hidenori Akaihata
JHJunya Hata
Junya Hata
RTRyo Tanji
Ryo Tanji
RHRuriko Honda-Takinami
Ruriko Honda-Takinami
YKYoshiyuki Kojima
Yoshiyuki Kojima
Chronic sympathetic hyperactivity is known to affect metabolism and cause various organ damage including bladder dysfunction. In this study, we evaluated whether l-theanine, a major amino acid found in green tea, ameliorates bladder dysfunction induced by chronic sympathetic hyperactivity as a dietary component for daily consumption. Spontaneously hypertensive rats (SHRs), as an animal model of bladder dysfunction, were divided into SHR–water and SHR–theanine groups. After 6 weeks of oral administration, the sympathetic nervous system, bladder function, and oxidative stress of bladder tissue were evaluated. The mean blood pressure, serum noradrenaline level, and media-to-lumen ratio of small arteries in the suburothelium were significantly lower in the SHR–theanine than in the SHR–water group. Micturition interval was significantly longer, and bladder capacity was significantly higher in the SHR–theanine than in the SHR–water group. Bladder strip contractility was also higher in the SHR–theanine than in the SHR–water group. Western blotting of bladder showed that expression of malondialdehyde was significantly lower in the SHR–theanine than in the SHR–water group. These results suggested that orally administered l-theanine may contribute at least partly to the prevention of bladder dysfunctions by inhibiting chronic sympathetic hyperactivity and protecting bladder contractility.

29 February 2016 in BMC Urology
Verified
Journal Article
Open access
PDF file
NKNobuhiro Kushida
Nobuhiro Kushida
OYOsamu Yamaguchi
Osamu Yamaguchi
YKYohei Kawashima
Yohei Kawashima
HAHidenori Akaihata
Hidenori Akaihata
JHJunya Hata
Junya Hata
YKYoshiyuki Kojima
Yoshiyuki Kojima
Excessive mechanical overload may be involved in bladder wall remodelling. Since the activity of Rho kinase is known to be upregulated in the obstructed bladder, we investigate the roles of the RhoA/Rho kinase pathway in mechanical overloaded bladder smooth muscle cells. Human bladder smooth muscle cells were stimulated on silicon culture plates by 15 % elongated uni-axial cyclic stretch at 1 Hz. The activity of c-Jun NH2-terminal kinase was measured by western blotting and actin stress fibers were observed by stained with phallotoxin conjugated with Alexa-Fluor 594. The activity of c-Jun NH2-terminal kinase 1 peaked at 30 min (4.7-fold increase vs. before stretch) and this activity was partially abrogated by the RhoA inhibitor, C3 exoenzoyme or by the Rho kinase inhibitor, Y-27632. Stretch induced the strong formation of actin stress fibers and these fibers re-orientated in a direction that was perpendicular to the stretch direction. The average angle of the fibers from the perpendicular to the direction of stretch was significantly different between before, and 4 h after, stretch. Actin stress fibers reorganization was also suppressed by the C3 exoenzyme or Y-27632. Bladder smooth muscle cells appear to have elaborate mechanisms for sensing mechanical stress and for adapting to mechanical stress overload by cytoskeletal remodeling and by activating cell growth signals such as c-Jun NH2-terminal kinase via RhoA/Rho kinase pathways.